Literature DB >> 24136242

Role of the PTEN signaling pathway in autism spectrum disorder.

Jing-Wen Lv1, Tian-Lin Cheng, Zi-Long Qiu, Wen-Hao Zhou.   

Abstract

Autism is an etiologically heterogeneous group of neurodevelopmental disorders, diagnosed mostly by the clinical behavioral phenotypes. The concept that the tumor-related gene PTEN plays a critical role in autism spectrum disorder has emerged over the last decade. In this review, we focus on the essential role of the PTEN signaling pathway in neuronal differentiation and the formation of neural circuitry, as well as genetic mouse models with Pten manipulations. Particularly, accumulated data suggest that the effect of PTEN on neural stem-cell development contributes significantly to the pathophysiology of autism spectrum disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136242      PMCID: PMC5562549          DOI: 10.1007/s12264-013-1382-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  54 in total

1.  BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels.

Authors:  Kristin A Waite; Charis Eng
Journal:  Hum Mol Genet       Date:  2003-03-15       Impact factor: 6.150

2.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.

Authors:  J Bertrand; A Mars; C Boyle; F Bove; M Yeargin-Allsopp; P Decoufle
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

3.  Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.

Authors:  M Groszer; R Erickson; D D Scripture-Adams; R Lesche; A Trumpp; J A Zack; H I Kornblum; X Liu; H Wu
Journal:  Science       Date:  2001-11-01       Impact factor: 47.728

4.  Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.

Authors:  Dan Ehninger; Alcino J Silva
Journal:  Behav Genet       Date:  2010-09-30       Impact factor: 2.805

Review 5.  Behavioural phenotyping assays for mouse models of autism.

Authors:  Jill L Silverman; Mu Yang; Catherine Lord; Jacqueline N Crawley
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

6.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Nicholas R Rensing; Bo Zhang; David H Gutmann; Michael J Gambello; Michael Wong
Journal:  Hum Mol Genet       Date:  2010-11-09       Impact factor: 6.150

7.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

Review 8.  PTEN signaling in brain: neuropathology and tumorigenesis.

Authors:  R Endersby; S J Baker
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

Review 9.  Autism and tuberous sclerosis.

Authors:  S L Smalley
Journal:  J Autism Dev Disord       Date:  1998-10

Review 10.  Epidemiological surveys of autism and other pervasive developmental disorders: an update.

Authors:  Eric Fombonne
Journal:  J Autism Dev Disord       Date:  2003-08
View more
  9 in total

Review 1.  The neural stem cell/carnitine malnutrition hypothesis: new prospects for effective reduction of autism risk?

Authors:  Vytas A Bankaitis; Zhigang Xie
Journal:  J Biol Chem       Date:  2019-11-07       Impact factor: 5.157

Review 2.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.

Authors:  Amanda K Tilot; Thomas W Frazier; Charis Eng
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

3.  Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders.

Authors:  Sean B Johnston; Ronald T Raines
Journal:  Biochemistry       Date:  2015-02-13       Impact factor: 3.162

4.  Inborn Errors of Long-Chain Fatty Acid β-Oxidation Link Neural Stem Cell Self-Renewal to Autism.

Authors:  Zhigang Xie; Albert Jones; Jude T Deeney; Seong Kwon Hur; Vytas A Bankaitis
Journal:  Cell Rep       Date:  2016-01-28       Impact factor: 9.423

Review 5.  Molecular Mechanisms of Aberrant Neuroplasticity in Autism Spectrum Disorders (Review).

Authors:  A A Anashkina; E I Erlykina
Journal:  Sovrem Tekhnologii Med       Date:  2021-02-28

6.  MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.

Authors:  Dejian Zhao; Mingyan Lin; Jian Chen; Erika Pedrosa; Anastasia Hrabovsky; H Matthew Fourcade; Deyou Zheng; Herbert M Lachman
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 7.  Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders.

Authors:  T C Theoharides; I Tsilioni; A B Patel; R Doyle
Journal:  Transl Psychiatry       Date:  2016-06-28       Impact factor: 6.222

Review 8.  Dendritic Integration Dysfunction in Neurodevelopmental Disorders.

Authors:  Andrew D Nelson; Kevin J Bender
Journal:  Dev Neurosci       Date:  2021-06-17       Impact factor: 3.421

9.  Prevalence and clinical/molecular characteristics of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly.

Authors:  Hande Kaymakcalan; İlyas Kaya; Nagihan Cevher Binici; Emrah Nikerel; Burcu Özbaran; Mehmet Görkem Aksoy; Seda Erbilgin; Gonca Özyurt; Noor Jahan; Didem Çelik; Kanay Yararbaş; Leyla Yalçınkaya; Sezen Köse; Sibel Durak; Adife Gulhan Ercan-Sencicek
Journal:  Mol Genet Genomic Med       Date:  2021-07-16       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.